Outcome

Hyperbaric Oxygen Therapy (HBOT) has been found to significantly improve cognitive functions in post-stroke patients even during the late chronic stage (>3 months post-stroke). In a study with 162 participants receiving 40 to 60 daily sessions of HBOT at 2 ATA 86% exhibited clinically significant improvements in at least one cognitive domain including memory executive function attention and motor skills.

Introduction

Stroke remains a leading cause of long-term disability often resulting in sustained cognitive impairments. Traditional therapies provide limited solutions for enhancing cognitive functions in patients who have long passed the acute stage. This study explores the impact of hyperbaric oxygen therapy (HBOT) on post-stroke cognitive function particularly in the late chronic stage defined as three months or more after the stroke event. Conducted over a decade the study evaluated 162 post-stroke patients who underwent 40 to 60 daily HBOT sessions each lasting 90 minutes at 2 atmospheres absolute (ATA) of 100% oxygen. Findings revealed that 86% of participants experienced clinically significant improvements in at least one cognitive domain such as memory executive function attention information processing speed and motor skills. Notably hemorrhagic stroke patients exhibited pronounced gains in information processing speed while those with strokes in the dominant hemisphere showed significant improvements in motor function. The study underscores that patient selection for HBOT should emphasize baseline cognitive scores and functional analysis over stroke type or lesion location highlighting HBOT as a promising intervention for long-term cognitive enhancement in post-stroke patients.

Results

The study found that hyperbaric oxygen therapy (HBOT) significantly improves cognitive functions in post-stroke patients even in the chronic stage (>3 months post-stroke). After 40 to 60 daily sessions of HBOT at 2 ATA 86% of patients showed clinically significant improvements in at least one cognitive domain including memory executive function attention and motor skills. Hemorrhagic stroke patients had higher improvements in information processing speed while patients with strokes in the dominant hemisphere showed larger motor function improvements. A low baseline memory score was a significant predictor for achieving clinically significant improvement. The study suggests that patient selection for HBOT should focus on functional analysis and baseline cognitive scores rather than stroke type or location.

Conclusion

In conclusion this study highlights the significant cognitive improvements that hyperbaric oxygen therapy (HBOT) can offer to post-stroke patients even those in the chronic stage beyond three months post-stroke. Through a comprehensive evaluation of 162 patients over a decade it was found that 86% of participants experienced clinically significant improvements in at least one cognitive domain—ranging from memory and executive function to attention information processing speed and motor skills—following 40 to 60 sessions of HBOT at 2 ATA. Notably hemorrhagic stroke patients showed greater enhancements in information processing speed while those with strokes in the dominant hemisphere demonstrated larger motor function improvements. The study also identified a low baseline memory score as a key predictor for achieving notable cognitive gains suggesting that patient selection for HBOT should prioritize initial cognitive assessments over specific stroke characteristics.

The findings accentuate the potential of HBOT as a valuable therapeutic approach for mitigating enduring cognitive deficits in chronic post-stroke patients. This research proposes a shift in patient selection criteria towards a more individualized analysis based on baseline cognitive function paving the way for more targeted and effective interventions. Future research could further elucidate the mechanisms behind these cognitive improvements and explore optimal HBOT protocols making it a cornerstone treatment in neurorehabilitation for post-stroke individuals.